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Abstract
Half of trauma deaths are attributable to hypovolemic circulatory collapse (HCC). We established a model of HCC in rats
involving minor trauma plus severe hemorrhagic shock (HS). HCC in this model was accompanied by a 50% reduction in
peak acceleration of aortic blood flow and cardiomyocyte apoptosis. HCC and apoptosis increased with increasing duration
of hypotension. Apoptosis required resuscitation, which provided an opportunity to intervene therapeutically.
Administration of IL-6 completely reversed HCC, prevented cardiac dysfunction and cardiomyocyte apoptosis, reduced
mortality 5-fold and activated intracardiac signal transducer and activator of transcription (STAT) 3. Pre-treatment of rats
with a selective inhibitor of Stat3, T40214, reduced the IL-6-mediated increase in cardiac Stat3 activity, blocked successful
resuscitation by IL-6 and reversed IL-6-mediated protection from cardiac apoptosis. The hearts of mice deficient in the
naturally occurring dominant negative isoform of Stat3, Stat3b, were completely resistant to HS-induced apoptosis.
Microarray analysis of hearts focusing on apoptosis related genes revealed that expression of 29% of apoptosis related
genes was altered in HS vs. sham rats. IL-6 treatment normalized the expression of these genes, while T40214 pretreatment
prevented IL-6-mediated normalization. Thus, cardiac dysfunction, cardiomyocyte apoptosis and induction of apoptosis
pathway genes are important components of HCC; IL-6 administration prevented HCC by blocking cardiomyocyte apoptosis
and induction of apoptosis pathway genes via Stat3 and warrants further study as a resuscitation adjuvant for prevention of
HCC and death in trauma patients.
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Introduction
Traumatic injury is the leading cause of death for people in the
first 4 decades of life in the United States [1] and other high-
income countries [2] and the second leading cause of death after
infectious diseases in low- and middle-income countries [2]. In
those surviving the immediate lethal injury, the most important
cause of death is hypovolemic circulatory collapse (HCC) [3]. The
proposed mechanisms for development of HCC are cardiac
dysfunction, abnormalities in vascular tone and capillary leak
[4,5]. Better delineation of the specific contributions of each of
these abnormalities to HCC and an understanding of the
molecular and cellular mechanisms underlying each abnormality
has the potential to yield new strategies to prevent HCC.
To gain new mechanistic insights and to develop resuscitation
strategies that prevent HCC, we developed a protocol in rats of
minor trauma plus severe HS that reproducibly results in HCC.
HCC in our model involves cardiac dysfunction secondary to
cardiomyocyte apoptosis. IL-6 administration at the start of
resuscitation prevents HCC, reverses cardiac dysfunction, improves
mortality and eliminates cardiomyocyte apoptosis, at least in part,
through activation of Stat3 which acts to normalize the shock-
induced apoptosis pathway transcriptome. These findings support
furtherinvestigation of IL-6, or other Stat3 activators, asan adjuvant
for resuscitation of trauma patients with severe HS to prevent HCC.
Methods
Rat and mouse protocols for trauma plus hemorrhagic
shock
These studies were approved by the Baylor College of Medicine
Institutional Review Board for animal experimentation and conform
to National Institutes of Health guidelines for the care and use of
laboratory animals. Adult male Sprague-Dawley rats were obtained
from Harlan (Indianapolis, IN). Stat3b homozygous-deficient
(Stat3b
D/D) mice were generated as described [6] and re-derived at
Jackson labs. Pups from heterozygous matings were tailed and
genotyped by PCR, as described, with minor modifications [6].
Rats (250–350 gm) were acclimatized and subjected to the sham
or hemorrhagic shock (HS) protocols, as described [7,8] with
modifications.Blood(22.5 ml/kg bodyweight)waswithdrawninto a
heparinized syringe over 10 min then episodically thereafter to
maintain the target MAP at 35 mmHg until blood pressure
compensation failed. Blood was then returned as needed to maintain
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different levels of shock severity reflected in the duration of
hypotension: 0% SBR (SBR0) represented the lowest level of shock
severity (duration of hypotension, 7862.5 minutes), 10% SBR
(SBR10; duration of hypotension, 149641.4 minutes), 20% SBR
(SBR20; duration of hypotension, 165632.7 minutes), 35% SBR
(SBR35; duration of hypotension, 21167.6 minutes), and 50% SBR
(SBR50; duration of hypotension, 273624.9 minutes). At the end of
the hypotensive period, rats were fluid resuscitated over 30 min as
described [7,8]. Fluid resuscitation consisted of return of the
remaining shed blood followed by a volume of Ringer’s solution
equal to 2 times the total shed blood volume. Ringer’s solution
contained a racemic mixture of L- and D-lactate. The MAP was
observed at the end of resuscitation to assess for hypovolemic
circulatory collapse (HCC) then the rats were humanely sacrificed
60 minutes after the start of resuscitation. HCC was defined as
failing to achieve a MAP at the end of fluid resuscitation within the
normal range of rats examined i.e. $72 mm Hg [the mean (94 mm
Hg) minus two SD (11 mm Hg) of starting BP]. Where indicated,
rats received 10 mg/kg of recombinant human IL-6 in 0.1 ml
phosphate-buffered saline (PBS, pH 7.4) at the initiation of
resuscitation or PBS alone. Sham rats were anesthetized and
cannulated for 250 minutes but were not subjected to hemorrhage
or resuscitation. One group of rats (UHS) was subjected to the most
severe hemorrhagic shock protocol (50% SBR), but not resuscitated
and kept at the targetMAP(35 mmHg)foran additional60 minutes
(duration of hypotension=336610.3 minutes) before sacrifice.
Stat3b
D/D mice and wild-type littermate mice were subjected to
a trauma/HS protocol [7,8], which was similar to the rat protocol
except that the target MAP in the mouse was 30 mm Hg and the
duration of hypotension was 180 min in all mice. Sham mice were
anesthetized and immobilized in a pair-wise fashion with HS mice
and sacrificed at the same time as their HS companion.
Rat and mouse hearts were harvested immediately after
sacrifice and snap frozen in liquid nitrogen.
In vivo pharmacological inhibition of Stat3
To achieve pharmacological inhibition of Stat3 activity within
the heart, rats were randomized to receive the G-quartet
oligodeoxynucleotide (GQ-ODN) T40214 or non-specific (NS)-
ODN (2.5 mg ODN/kg) complexed in polyethyleneimine by tail
vein injection, as described [9], 24 hours prior to subjecting them
to SBR50 protocol. Fluorescently labeled T40214 when delivered
in this fashion was previously shown to accumulate within the cells
of a variety of normal tissues including heart, liver and kidneys
(Jing N, unpublished data 2003) as well as tumor tissue [9]; half-life
of T40214 within tumors and surrounding normal tissue was
$48 hr.
Doppler ultrasound studies
A 20 MHz Doppler ultrasound probe custom-built was used for
these studies. Rats were subjected to Doppler evaluation, 60 min
after the start of resuscitation, as described [10].
ELISA detection of cytoplasmic nucleosomes
Determination of cytoplasmic histone-associated DNA fragments
(nucleosomes)was performed using the Cell Death Detection ELISA
Plus Kit (Roche), following the instructions of the manufacturer and
modified for detection of nucleosomes within tissues.
TUNEL staining
TUNEL was performed using the ApopTagH Plus Peroxidase In
Situ Apoptosis Detection Kit following the manufacturer’s instruction.
Electrophoretic mobility shift assay (EMSA)
EMSA was performed using heart tissue extracts from
experimental groups as described [7]. The level of transcription
factor activation was quantitated using PhosphorImager analysis
combining the intensities of the Stat3 homodimer and Stat3/Stat1
heterodimer gel shift bands.
Immunoblotting
Levels of Stat3 activation within the hearts of rats were assessed
by immunoblotting using whole-tissue extracts of heart sections
with mouse monoclonal antibody to Tyr705 phosphorylated
(p)Stat3 (Cell Signaling Technology, Inc., Danvers, MA; 1:1000
dilution), as described [11]. The membrane was then stripped
(using Restore
TM Western Blot Stripping Buffer, PIERCE,
Rockford, IL) and immunoblotting performed to detect total
Stat3 protein in the whole tissue extracts of hearts using mouse
IgG1 monoclonal antibody to Stat3 (BD Biosciences, Rockville,
MD). Densitometry was performed using ImageQuant TL v2005
software (Amersham Biosciences, Buckinghamshire, England).
Results are expressed as the ratio of pSTAT3 signal (after
background signal subtraction) to total STAT3 signal (after
background signal subtraction) for each sample.
RNA isolation and oligonucleotide microarray
hybridization
Total RNA was isolated from 4-5 micron cryotome slices of the
frozen ventricular tissue using TRIzolH Reagent (Invitrogen,
Carlsbad, California) single step RNA isolation protocol followed
by purification with RNeasyH Mini Kit (QIAGEN, Hilden,
Germany) as instructed by the manufacturer. Gene expression
profiling was performed with the Affymetrix Rat Array RAE 230A
following Affymetrix protocols used within the Baylor College of
Medicine Microarray Core Facility.
Microarray Analysis
We used Affymetrics GCOS (www.affymetrix.com), dChip [12]
(www.dchip.org) and Array Analyzer (www.insightful.com) soft-
ware packages for quality assessment and statistical analysis and
annotation. Expression estimation and group comparisons were
done with Array Analyzer.
Low-level analyses included background correction, quartile
normalization and expression estimation using GCRMA [13].
One-way analysis of variance (ANOVA) with contrasts [14] was
used for group comparisons on all genes and on the list of apoptosis
pathway genesonly.P valueswereadjusted formultiplecomparisons
using the BH (Benjamini-Hochberg) method [15], which provides a
good balance between discovery of statistically significant differences
and minimization of false-positive occurrences. The adjusted p-
values are the false discovery rates (FDR), which represent the
proportion of ‘‘significant’’ genes vs. those that are false or spurious
‘‘discoveries’’. We used a FDR=10% as cut-off, which is near the
conservative end of the desirable range ,50% [16].
Quantitative reverse transcription-polymerase chain
reaction (Q-RT-PCR)
To validate gene expression patterns of microarray hybridiza-
tion, we performed Q-RT-PCR as described [8] for 4 genes (Mcl-
1, Bcl-xL, Tob1 and Atf3).
Statistical analysis
Statistical differences were analyzed using one-way ANOVA
and the Student-Newman-Keuls test, Student’s t test and Fischer’s
exact test where appropriate.
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HCC is accompanied by left ventricular contractile
dysfunction and cardiomyocyte apoptosis
To gain insight into mechanisms of hypovolemic circulatory
collapse (HCC) at the organ, cellular and molecular level, we
established conditions for HCC in a rat model of trauma/
hemorrhagic shock (HS) by increasing the duration of the
hypotensive phase (Table 1). HCC was not observed with periods
of hypotension up to 165 min (0 to 20% shed blood return; SBR0,
SBR10 and SBR20, groups) but occurred in 20% of the SBR35
rats and 67% of SBR50 rats (hypotensive phase=21167.6 and
273624.9 min, respectively).
It has been demonstrated in non-rodent animal models that
cardiac dysfunction contributes to HCC [4,5]. To determine if this
was the case in our rat model, we performed Doppler ultrasound
studies of the ascending aorta of SBR50 rats (Figure 1); peak aortic
acceleration has been demonstrated previously to be a good
noninvasive index of cardiac contractile function in animals
[10,17]. Peak aortic acceleration in the SBR50 rats (6,974 cm/s
2)
was reduced by 50% compared to sham rats (14,061 cm/s
2;
p,0.05) indicating that HCC in rats was accompanied by left
ventricular contractile dysfunction.
Cardiomyocyte apoptosis has been observed in other settings of
ventricular contractile dysfunction such as following myocardial
infarction [18]. To assess if HCC is accompanied by cardiomy-
ocyte apoptosis, we evaluated the hearts of rats for apoptosis using
two assays—nucleosome ELISA and TUNEL staining. Nucleo-
somes levels (Figures 2 and 3A) were low in sham rat hearts
(4.6261.32 units/mg total protein) and did not increase in the
hearts of SBR0, SBR10 or SBR20 rats. However, nucleosomes
levels were increased nearly 10-fold over sham in SBR35 rats
(45.64627.8 units/mg total protein, p,0.01, ANOVA) and 36-
fold over sham in SBR50 rats (167.3624.9 units/mg total protein,
p,0.01, ANOVA). The 3.7-fold increase in apoptosis in the
SBR50 vs. SBR35 rats correlated well with the 3.3-fold increase in
HCC in the SBR50 vs. SBR35 rats (Table 1). Results of TUNEL
staining confirmed the nucleosome findings and indicated that
cardiomyocyte nuclei were the major contributor to nucleosomes
(Figure 3B and 3C).
To determine the contribution of resuscitation to cardiac
apoptosis, we assessed nucleosome levels in the hearts of rats
subjected to HS without resuscitation (UHS group, Figure 2;
hypotensive phase=336610.3 min). The level of nucleosomes in
the UHS group (8.162.3 units/mg total protein) was less than
18% of the value in the hearts of SBR35 rats (45.64627.8 units/
mg total protein, p,0.001, ANOVA) and less than 5% of the
value in the hearts of the SBR50 group (167.3624.9 units/mg
total protein, p,0.001 ANOVA) indicating that resuscitation is
required for virtually all HS-induced cardiac apoptosis. Results of
TUNEL-staining confirmed the nucleosome findings; the number
of TUNEL-positive nuclei/1,000X field in the hearts of UHS rats
(2.260.5) was similar to sham rats (1.360.3; p.0.05). These
results extend to the heart previous findings suggesting that
resuscitation is needed for HS-induced liver, small intestine and
lung apoptosis [19,20] and suggest that interventions initiated at
the start of resuscitation have the potential to prevent cardiomy-
ocyte apoptosis along with HCC.
IL-6 reverses HCC, ventricular contractile dysfunction and
cardiomyocyte apoptosis
We investigated whether administration of IL-6, a cytokine with
anti-apoptotic properties, at the start of resuscitation to rats
subjected to 50% SBR could prevent HCC (Figure 4). All SBR50
rats that received IL-6 (SBR50/IL-6 rats) were successfully
resuscitated, compared to only 33% of placebo-treated SBR50
rats (p,0.05, Fisher’s exact test). The post-resuscitation MAP for
the placebo group decreased to 69619 mm Hg from a baseline
MAP of 8665m mH g( p ,0.05; Student’s t-test). In contrast, the
post-resuscitation MAP of the rats that received IL-6 (91612 mm
Hg) was essentially identical to their starting MAP (9469 mm Hg).
To determine if prevention of HCC by IL-6 was a result of
improved left ventricular contractile function, we determined peak
aortic acceleration of SBR50/IL-6 rats and compared the results
with placebo-treated SBR50 rats (Figure 1). Resuscitation with IL-
6 completely reversed the trauma/HS-induced ventricular con-
tractile dysfunction (p,0.05, one-way ANOVA with Student-
Newman-Keuls test). To determine if cardiomyocyte apoptosis
following trauma/HS is reversed by IL-6, we performed
Table 1. Incidence of HCC with increasing duration of the
hypotensive phase.
Group (% SBR)
2,3 Duration of hypotensive % with HCC
1
Phase (min, mean6SD)
07 8 62.5 0
10 149641.4 0
20 165632.7 0
35 21167.6 20
50 273624.9 67
1Defined as failure to achieve a MAP at the end of resuscitation within the
normal range i.e. $72 mm Hg [the mean (94 mm Hg) minus two SD (11 mm
Hg) of starting BP].
2SBR=shed blood return
3n$3
doi:10.1371/journal.pone.0001605.t001
Figure 1. Effect of trauma/HS without or with IL-6 on peak
acceleration of aortic blood flow. Rats were subjected to the sham
or the SBR50 protocol; SBR50 rats were randomly assigned to receive
either placebo or IL-6 at the start of resuscitation (n$3 in each group).
Sixty minutes after start of resuscitation or at the equivalent time point
for shams, rats underwent Doppler studies of the ascending aorta. Data
presented is the mean6SEM of peak acceleration of aortic blood flow;
significant differences are indicated (one-way ANOVA followed by
Student-Newman-Kuels test).
doi:10.1371/journal.pone.0001605.g001
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from SBR50/IL-6 rats were reduced 94% compared to placebo-
treated SBR50 rats (p,0.05, one-way ANOVA with Student-
Newman-Keuls test). TUNEL assays of sections of rat hearts
confirmed these findings (Figure 3B and 3C).
IL-6 decreases mortality after trauma and HS
Mortality following initially successful resuscitation from severe
HS results from multi-organ dysfunction or failure [4,5]. Following
resuscitation, all SBR50 rats died regardless of whether or not they
received IL-6 suggesting that the 50% SBR protocol caused failure
of one or more vital organ(s) other than the heart that was not
reversed by IL-6. To investigate the impact of IL-6 on mortality
after trauma plus hemorrhage, SBR35 rats, which also experi-
enced HCC and cardiomyocyte apoptosis (Table 1 and Figure 2),
were randomized to receive either placebo or IL-6 (10 mg/kg) at
the start of resuscitation (Figure 5). Similar to the effect of IL-6
treatment on HCC in the SBR50 group, all animals in the
SBR35/IL-6 group were successfully resuscitated compared to
80% of rats in the placebo-treated SBR35 group (data not shown).
Furthermore, mortality was reduced nearly 5 fold from 72% in
placebo-treated SBR35 rats to 15.4% in SBR35/IL-6 group
(p,0.005, Kaplan-Meier survival analysis).
The ability of IL-6 to prevent HCC and cardiomyocyte
apoptosis is Stat3 dependent
IL-6 activates Stat3, which has previously been demonstrated to
activate the transcription of several anti-apoptotic genes and to
contribute to apoptosis resistance in cancer cells (reviewed in [21]).
To assess if the anti-apoptotic effect of IL-6 is mediated by Stat3
activation, we first determined if Stat3 is activated in the hearts of
rats resuscitated with IL-6. Extracts of cryotome sections of the
heart harvested 1 hour after IL-6 administration were examined
by EMSA using radiolabeled duplex hSIE (Figure 6). Stat3-
containing gel-shift bands, SIF-A and SIF-B (Stat3 homodimers
and Stat3:Stat1 heterodimers, respectively) were more readily
detected in heart extracts from SBR50/IL-6 rats than in heart
extracts from placebo-treated SBR50 rats. Phosphoimaging
analysis of Stat3-containing bands indicated that Stat3 DNA-
binding activity is increased over two fold in the hearts of SBR50/
IL-6 rats compared to placebo-treated SBR50 rats (p=0.028,
Student’s t-test). Levels of phosphorylated Stat3 within hearts of
SBR50/IL-6 rats also were increased, which confirmed the EMSA
results (data not shown).
To determine if activation of Stat3 downstream of IL-6 was
important for the improved resuscitation success observed in
SBR50/IL-6 rats, we pre-treated rats 24 hr before SBR50 and IL-
6 resuscitation with a G-rich, quartet forming oligodeoxynucleo-
tide (GQ-ODN, T40214) that specifically binds to and inhibits the
activity of Stat3 [9] or with a non-specific oligodeoxynucleotide
(NS-ODN). Stat3 DNA-binding activity was reduced 3-fold within
the hearts of SBR50/IL-6/GQ compared to SBR50/IL-6/NS rats
(Figure 7). Levels of phosphorylated Stat3 within hearts of SBR50/
IL-6/GQ rats also were decreased compared to SBR50/IL-6/NS
rats, which confirmed the EMSA results (data not shown).
Resuscitationwassuccessfulinonly13%ofSBR50/IL-6/GQrats
while resuscitation was successful in 94% of SBR50/IL-6/NS rats
(p,0.05, Fisher’s exact test; Figure 4). To determine if IL-6
activation of Stat3 was also important for the anti-apoptotic effects of
IL-6 in SBR50, we examined the hearts of SBR50/IL-6 rats pre-
treated with GQ-ODN vs. NS-ODN for nucleosome levels and
TUNEL-positive nuclei. Nucleosome levels in the hearts of SBR50/
IL-6/GQrats(Figure3A)wereincreased10-foldcomparedtohearts
from SBR50/IL-6 rats (p,0.05, one-way ANOVA with Student-
Newman-Keuls test). Similarly, the number of TUNEL-positive
nuclei in SBR50/IL-6/GQ rats was similar to that of placebo-
treated SBR50 rats (Figure 3B and 3C). In contrast, nucleosome
levelsintheheartsofSBR50/IL-6/NSratswerevirtuallyidenticalto
the levels in the SBR50/IL-6 group (Figure 3A); the results of
TUNEL staining in SBR50/IL-6/NS rats (Figure 3B and 3C) were
consistent with the nucleosome results. Together these results
Figure 2. Effect of duration of hypotension and resuscitation on cardiac nucleosome levels. Rats (n$3 in each group) were subjected to
sham protocol (S) or the trauma/HS protocol with increasing severity of shock (SBR0, SBR10, SBR20, SBR35, and SBR50) as indicated followed by
resuscitation. Hearts were harvested 60 minutes after the start of resuscitation. One group of rats (UHS) was subjected to the SBR50 protocol, but not
resuscitated, rather, kept at the target MAP (35 mmHg) for an additional 60 minutes. Hearts were immediately harvested and snap frozen in liquid
nitrogen. Nucleosome levels were measured in protein extracts of frozen sections of the heart and the results corrected for total protein and plotted
as a function of the duration of the hypotensive period. Nucleosome levels increased exponentially with duration of hypotension (Pearson correlation
coefficient=0.764, p,0.0001, UHS group not included in the analysis).
doi:10.1371/journal.pone.0001605.g002
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6 in preventing cardiomyocyte apoptosis.
Two isoforms of Stat3 are expressed in all cells—a (p92) and b
(p83)—both derived from a single gene by alternative mRNA
splicing with Stat3a predominating. Stat3a functions as an
oncogene [22] , in part, through inhibiting apoptosis, while Statb
antagonizes the oncogenic function of Stat3a [23]. While mice
deficient in both isoforms of Stat3 are embryonic lethal at day 6.5
to 7 [24] and mice deficient in Stat3a die within 24 hr of birth,
mice deficient in Stat3b have normal survival and fertility [6]. To
further support the hypothesis that Stat3, in particular Stat3a,
contributes to resistance to apoptosis within the heart in the setting
of HS, we subjected Stat3b homozygous-deficient (Stat3b
D/D)
mice and their littermate control wild type mice to a severe HS
protocol (target MAP 30 mm Hg for 5 hr) and examined their
hearts for nucleosome levels 1 hr after the start of resuscitation
(Figure 8). As expected, nucleosome levels in wild type HS mice
were increased compared to wild type sham mice (p,0.006). In
contrast, however, nucleosome levels in the hearts of Stat3b
D/D
HS mice were reduced 88% compared to wild type HS mice and
were similar to sham mice. These findings indicate that Stat3, in
particular Stat3a, protects the heart from apoptosis in the setting
of severe HS.
Microarray analysis of the cardiac transcriptome focusing
on differential expression of apoptosis pathway genes
The balance of pro- and anti-apoptotic proteins within the cell is
regulated largely at the transcriptional level. Stat3 directly
activates gene transcription and also interferes with the function
of other transcription factors such as NF-kB [25], which previously
has been shown to be activated following resuscitation from HS
[7]. To identify apoptosis-related genes modulated within the
hearts of animals suffering from HCC and to gain insight at the
transcriptome level regarding how IL-6 protects against cardio-
myocyte apoptosis, we performed Affymetrix oligonucleotide
microarray analysis with RAE 230A chips. Initially, 12 chips
were hybridized using mRNA isolated from 4 hearts each of sham,
SBR50/P and SBR50/IL-6 rats. A separate experiment with 8
chips (4 in each group) was performed to compare SBR50/IL-6/
GQ with SBR50/IL-6/NS groups. The 15,923 probesets on the
RAE 230A chip represent 13,521 annotated genes or expressed
sequence tags, including 859 apoptosis-related genes (Table S1,
Supporting information files). The list of 859 apoptosis-related
genes present on the REA 230A was created by combining gene
lists obtained by querying annotation databases provided in
Affymetrix, GeneSpring, and dChip derived from the Gene
Ontology (GO) Consortium.
To identify genes differentially expressed among the three
experimental groups (sham, SBR50, SBR50/IL-6), the data were
filtered to remove genes with nearly uniformly low expression
(absent on 80% of chips). Of the 859 apoptosis related genes
present on the chips, 682 genes met the requirement of this
Figure 4. Resuscitation success following trauma/HS without or
with IL-6 treatment; impact of Stat3 inhibition on the IL-6
effect. Rats were subjected to the 50% shed blood return protocol
(SBR50) and randomized in a blinded fashion to receive either placebo
(n=6) or IL-6 (n=7) at the start of resuscitation as indicated. Two
additional groups of rats were randomly assigned 24 hr prior to SBR50
and IL-6 treatment to receive pretreatment with GQ-ODN or non-
specific (NS)-ODN by tail vein injection as indicated (n$7). Data
presented is the percent resuscitation success for each group defined as
achieving a MAP $mean MAP minus 2 SD of starting BP. Significant
differences are indicated (Fisher’s exact test).
doi:10.1371/journal.pone.0001605.g004
Figure 3. Effect of trauma/HS without or with IL-6 on cardiac
apoptosis; impact of Stat3 inhibition on the IL-6 effect. Rats
(n$3 in each group) were randomly assigned to the sham or SBR50
protocol; SBR50 rats were randomized 24 hr prior to trauma/HS not to
receive pretreatment or to receive pretreatment with GQ-ODN or non-
specific (NS)-ODN by tail vein injection as indicated. At the start of
resuscitation, rats in the first two SBR50 groups were randomized in a
blinded fashion to receive either placebo or IL-6 at the start of
resuscitation; each rat in the last two SBR50 groups received IL-6. In
panel A, extracts of cryotome sections of flash-frozen ventricles
obtained 60 minutes after the start of resuscitation were used to
measure nucleosome levels by ELISA. Data presented are the mean6
SEM of nucleosome levels (Units/mg protein); significant differences are
indicated (one-way ANOVA followed by Student-Newman-Kuels test). In
panel B, sections of fixed ventricles were stained using the TUNEL
protocol; representative slides showing TUNEL-positive cells (arrows)
are shown. In panel C, the number of TUNEL-positive nuclei was
counted in twenty randomly chosen fields of each slide by an
experienced microscopist blinded to the treatment the rats received.
Data presented are mean number of TUNEL-positive nuclei per
field6SEM for each group; significant differences are indicated (one-
way ANOVA followed by Student-Newman-Kuels test).
doi:10.1371/journal.pone.0001605.g003
IL-6, Stat3. Circ. Collapse
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way ANOVA (see Materials and Methods) was then performed
which identified 201 apoptosis related genes with differential
expression among the three groups at a False Discovery Rate
(FDR)=10%. Of the 201 apoptosis related genes whose
expression was altered among the three groups, 196 were altered
in the SBR50 vs. sham groups (Table S2 and Figure 9A). The
majority (135 genes transcripts) were increased in SBR50 vs. sham
by 1.1 to 75 fold while 61 gene transcripts were decreased in
SBR50 vs. sham by 1.1 to 1.9 fold.
The overall effect of IL-6 administration on both sets of
apoptosis-related gene transcripts was to ‘‘normalize’’ the
alterations induced by trauma/HS (Figure 9B). Thirty-five (35)
Figure 5. Effect of IL-6 on mortality following HS. Rats were subjected to the SBR35 protocol and randomized in a blinded fashion to receive
either placebo (0.1 ml PBS; n=25; SBR35/P; filled triangles) or IL-6 (10 mg/kg in 0.1 ml PBS; n=26; SBR35/IL-6; filled squares) at the start of
resuscitation. At the end of the resuscitation period, catheters were removed and anesthesia was reversed. Mortality was monitored and cumulative
survival was plotted per Kaplan-Meier analysis (p,0.005).
doi:10.1371/journal.pone.0001605.g005
Figure 6. Effect of IL-6 on cardiac Stat3 activity. Rats were
subjected to the SBR50 protocol and randomized in a blinded fashion
to receive either placebo (0.1 ml PBS; 2) or IL-6 (10 mg/kg in 0.1 ml PBS;
+). Extracts (20 mg) of cryotome sections of flash-frozen ventricles were
analyzed by EMSA; radiolabeled probe without cell extract (Neg) or an
extract of cells previously shown to have Stat3 activity (Pos) were
included as negative and positive controls, respectively. After separa-
tion, the gel was dried and autoradiographed (panel A) or subjected to
phosphoimaging analysis (panel B). Data presented in panel B
represents the mean6SD of the densitometry readings; significant
differences are indicated (Student’s t-test).
doi:10.1371/journal.pone.0001605.g006
Figure 7. Effect of pretreatment with a Stat3 inhibitor on IL-6-
induced Stat3 activity within the heart. Rats were pre-treated with
GQ-ODN or NS-ODN and subjected to the SBR50 protocol and
resuscitated with IL-6 (10 mg/kg in 0.1 ml PBS). Extracts of cryotome
sections of flash-frozen ventricles were analyzed by EMSA; radiolabeled
probe without cell extract (Neg) or an extract of cells previously shown to
have Stat3 activity (Pos) were included as negative and positive controls,
respectively. After separation, the gel was dried and autoradiographed
(panel A) or subjected to phosphoimaging analysis (panel B). Data
presented in panel B represents the mean6SD of the densitometry
readings; significant differences are indicated (Student’s t-test).
doi:10.1371/journal.pone.0001605.g007
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sham groups were decreased significantly in the SBR50/IL-6 vs.
SBR50 groups by 1.3 to 10.8 fold. Of the remaining 100 genes
whose transcripts levels were increased, 84 were also decreased in
the SBR50/IL-6 vs. SBR50 groups, although the decreases did not
achieve statistical significance. Five (5) of the 61 gene transcripts that
were decreased in the SBR50 vs. sham groups were increased
significantly in the SBR50/IL-6 vs. SBR50 groups by 1.3 to 6.3 fold
(Table S2). Of the remaining 56 genes whose transcript levels were
decreased in the SBR50/IL-6 vs. SBR50 groups, 48 were increased
although the increases did not achieve statistical significance. Thus,
combining apoptosis-related gene transcripts that were both
increased and decreased by trauma/HS (196 total), IL-6 treatment
altered levels towards sham or normal in 172 (88%) of them.
Microarray analysis of hearts from SBR50/IL-6/GQ and
SBR50/IL-6/NS rats identified 268 of the 682 apoptosis-related
genes detected in the first microarray experiment whose
expression was altered between the two groups (Table S2 and
Figure 9A). One hundred and fourteen genes overlapped with the
201 genes identified within the first 3 groups. The overall effect of
pharmacological inhibition of Stat3 in the apoptosis-related genes
was to prevent the ‘‘normalizing’’ effect of IL-6 administration
(Figure 9B). Specifically, of the 40 gene transcripts ‘‘normalized’’
statistically by IL-6 administration, 28 (70%) were significantly
modulated within the SBR50/IL-6/NS rat hearts compared to the
SBR50/IL-6/GQ rat hearts in the direction consistent with the
hypothesis that IL-6 ‘‘normalized’’ SBR50/P-induced changes in
gene transcript levels through activation of Stat3.
Q-RT-PCR was performed on a subset of the 201 genes whose
expression was altered in the first microarray analysis and on Bcl-
xL to establish the concordance rate of alteration in gene
expression determined by microarrays with Q-RT-PCR, an
alternative method for assessing levels of gene expression. The
rate of agreement between microarrays and Q-RT-PCR in the
direction of change in gene expression was 75%, which was similar
to or better than reported by others [26].
Discussion
We developed a hemorrhagic shock protocol in rats that models
hypovolemic circulatory collapse (HCC). HCC in this model was
accompanied by left ventricular contractile dysfunction secondary,
at least in part, to cardiomyocyte apoptosis. HCC and cardiomy-
ocyte apoptosis increased with increasing duration of hypotension.
Apoptosis required resuscitation which provided an opportunity
for therapeutic interventions. Administration of IL-6 at the start of
resuscitation prevented HCC, improved left ventricular function,
reversed cardiomyocyte apoptosis, reduced mortality and activated
intracardiac Stat3. Pretreatment of rats with a specific GQ-ODN
inhibitor of Stat3, T40214, blocked IL-6-mediated activation of
intracardiac Stat3 and the ability of IL-6 to prevent HCC and
cardiomyocyte apoptosis. The hearts of mice deficient in the
naturally occurring dominant negative isoform of Stat3, Stat3b,
were completely resistant to HS-induced apoptosis confirming a
role for Stat3, particularly Stat3a, in this process. Microarray
analysis of hearts focusing on apoptosis pathway genes revealed
that expression of 29% of apoptosis-pathway genes was altered in
SBR50 vs. sham rats. The overall effect of IL-6 treatment was to
normalize the expression of these genes, while T40214 pretreat-
ment prevented their normalization by IL-6. Thus, cardiomyocyte
apoptosis occurs in our model of severe HS and contributes to left
ventricular dysfunction and HCC; the cardioprotective effects of
IL-6 in HCC are mediated in part by Stat3 through its ability to
prevent cardiomyocyte apoptosis and ‘‘normalize’’ the shock-
induced, apoptosis pathway transcriptome.
While left ventricular dysfunction in severe HS and its physiolog-
ical details were reported over half a century ago [4], its cellular and
molecular basis has remained incompletely defined. Cardiomyocyte
apoptosis has been well described in other cardiac insults including
rodent coronary artery occlusion models [18]. Furthermore,
transgenic over-expression of the anti-apoptotic protein Bcl-2 within
cardiomyocytes [18] resulted in decreased cardiac apoptosis and
improvement in ventricular function. While apoptosis has been
demonstrated in multiple organs after HS, it has not been previously
demonstrated to occur within the heart following this insult. We
observed a striking correlation between cardiomyocyte apoptosis and
development of HCC in our rat model (Table 1 and Figure 3).
Apoptosis was not detected within the hearts of SBR0, SBR10 and
SBR20 rats in which HCC did not occur; rather, it was detected only
in SBR35 and SBR50 rats that experienced HCC. In addition, the
3.7-fold increase in cardiac apoptosis in SBR50 vs. SBR35 rats was
matched by a 3.4-fold increase in the incidence of HCC in SBR50 vs.
SBR35rats.Inaddition,IL-6administration,whichpreventedHCC,
also prevented cardiomyocyte apoptosis along with left ventricular
dysfunction. Together, these findings strongly support the hypothesis
that cardiomyocyte apoptosis contributesto HCCand leftventricular
dysfunction following trauma/HS.
Binding of IL-6to its receptor activates Stat3 (reviewed in [27]). In
vitro and in vivo findings of others have provided evidence that Stat3
protects against cardiomyocyte apoptosis in some cardiac insults
including ischemia-reperfusion injuries [28,29]. However, the role of
cardiac Stat3 in HS has not been investigated. We observed an
increase in Stat3 activity within the hearts of rats that received IL-6
compared to placebo-treated rats. Furthermore, we determined that
pre-treatment of rats with a specific GQ-ODN inhibitor of Stat3
blocked the IL-6-mediated increase in intra-cardiac Stat3 activity
along with the ability of IL-6 to prevent HCC and to inhibit
Figure 8. Effect of Stat3b ablation on trauma/HS-induced
cardiac apoptosis. Stat3b homozygous-deficient (Stat3b
D/D) mice
and their littermate control wild type mice were subjected to the
murine trauma/HS protocol or sham protocol and their hearts harvested
1 hr after the start of resuscitation. Nucleosome levels were measured in
protein extracts of frozen sections of the heart and the results corrected
for total protein. Data presented are the means6SEM of each group
(n$3). Significant differences are indicated (Student’s t-test)
doi:10.1371/journal.pone.0001605.g008
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the cardioprotective effects of IL-6, in large measure. The finding
that the hearts of mice deficient in the naturally occurring dominant-
negative isoform of Stat3, Stat3b, were completely resistant to HS-
induced apoptosis lends strong support to this conclusion.
The functions of Stat3 identified to date involve regulation of
gene transcription. The best-characterized transcriptional function
of Stat3 is activation of gene transcription through binding to
acute phase response elements (APRE) within gene promoters
(reviewed in [21]). However, more recently, Stat3 also has been
demonstrated to selectively inhibit transcription of specific genes
such as Fas and the endothelial isoform of nitric oxide synthase
(eNOS) [30,31]; inhibition, in some cases, is mediated by
cooperation with or interference of other transcription factors,
notably c-Jun and NF-kB, respectively [25,30].
Whether a cell survives or undergoes apoptosis in response to
injury or stress is determined by the balance of anti- and pro-
apoptotic proteins within the cell. The level of anti- and pro-
apoptotic proteins is determined largely at the transcriptional level.
To assess which apoptosis-related gene transcripts are altered
within the hearts of rats by trauma/HS that lead to apoptosis and
whether or not IL-6 alters this pattern of expression thereby
tipping the balance away from apoptosis, we performed a global
assessment of apoptosis-related gene transcript levels using
microarray analysis. We identified 859 apoptosis-related genes
contained within the RAE 230A GeneChip (Table S1) of which
682 were detectably expressed on 20% or more of the chips
hybridized with heart mRNA. One hundred and ninety-six of
these 682 genes (29%) were altered in the hearts of SBR50 vs.
sham rats; this percentage of apoptosis genes altered was 2.1 fold
greater than all the genes altered between SBR50 and sham hearts
underscores the importance of the apoptosis gene pathway in our
trauma/HS model at the transcriptome level (probability of
equality of these proportions is less than 0.001).
Figure 9. Effect of trauma/HS without or with IL-6 treatment on cardiac apoptosis-related gene expression; impact of Stat3
inhibition on the IL-6 effect. A. Heat map of apoptosis pathway genes whose expression is altered by trauma/HS. Rows in the heat map represent
genes as listed in Table 1. Columns represent samples from the 3 groups examined in Experiment 1 (left panel) as indicated (S, Sham; P, placebo-
treated SBR50; and I, SBR50/IL-6) and the 2 groups examined in Experiment 2 (right panel) as indicated (N, SBR50/IL-6/NS and G, SBR50/IL-6/GQ-ODN).
Red indicates a level of expression above the mean expression of a gene within the experiment. White indicates a level of expression at the mean
within the experiment while blue indicates a level of expression below the mean within the experiment. B and C. Changes in expression levels of
apoptosis-related genes are shown comparing SBR50 vs. sham (open bars), SBR50/IL-6 vs. SBR50 (gray bars) and SBR50/IL-6/G vs. SBR50/IL-6/N
(stippled bars). In panel B, the 196 apoptosis-related genes whose expression levels were changed in SBR50 vs. sham in the first microarray
experiment were separated into those genes whose transcript levels were increased in SBR50 vs. sham (135 genes; left side of panel) and those
whose transcript levels were decreased in SBR50 vs. sham (61 genes; right panel). In panel C, the 196 apoptosis-related genes whose expression levels
were changed in SBR50 vs. sham in the first microarray experiment were separated into anti-apoptotic genes whose transcript levels were altered in
SBR50 vs. sham (115 genes; left side of panel) and pro-apoptotic genes whose transcript levels were altered in SBR50 vs. sham (81 genes; right panel).
doi:10.1371/journal.pone.0001605.g009
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in the SBR50/IL-6 vs. SBR50 group was 47 of which 44 (95%)
belong to the apoptosis-related gene set (Table S1). Thus, the
striking effect of IL-6 on cardiomyocyte apoptosis is reflected in its
effect on the transcriptome being predominantly within the
apoptosis-related gene set. Importantly, the predominant alter-
ation found within 40 of these 44 genes altered in SBR50/IL-6 vs.
SBR50 was ‘‘normalization’’ i.e. a return of their mRNA levels to
sham levels. These findings strongly support the hypothesis that
trauma/HS leads to an alteration in the balance of anti- and pro-
apoptotic proteins that favors apoptosis and that IL-6 moves the
balance away from apoptosis and back to ‘‘normal’’ or sham.
The findings from the second microarray analysis of hearts from
SBR50/IL-6/NS and SBR50/IL-6/GQ rats indicates that Stat3
activation downstream of IL-6 is responsible, in large measure, for
this normalizing effect of IL-6 upon the apoptosis transcriptome.
Of the 40 genes that were normalized by IL-6 administration, 28
(70%) were modulated within the NS-ODN vs. GQ-ODN groups
in the direction consistent with the hypothesis that Stat3 mediated
the normalizing effect. Of these 28 genes, 27 genes were
normalized by virtue of being decreased in the NS-ODN vs. the
GQ-ODN group. Thus, the major effect of IL-6-activated Stat3
appears to be suppression of apoptosis related gene induction. The
ability of Stat3 to inhibit gene transcription previously has been
proposed to explain the anti-inflammatory effects of Stat3
activated downstream of IL-10 [32]. Our findings indicate that
this is also the major way that IL-6-activated Stat3 modulates
apoptosis following trauma and severe HS.
To determine which subset of apoptosis-related gene tran-
scripts—anti-apoptotic, pro-apoptotic or both—were altered by
trauma/HS and subsequently normalized by IL-6-activated Stat3,
we analyzed each subset of transcripts separately (Figure 9C).
Interestingly, gene transcript levels within both anti- and pro-
apoptotic subsets were increased by trauma/HS; furthermore,
transcripts within both subsets were normalized by IL-6, an effect
that was reversed by pre-treatment with the Stat3 inhibitor,
T0214. Since normalization by reduction of anti-apoptotic gene
transcripts is very unlikely to protect from apoptosis, this analysis
strongly suggests that trauma/HS results in cardiomyocyte
apoptosis through upregulation of pro-apoptotic genes and that
IL-6-activated Stat3 protects cardiomyocytes from apoptosis by
inhibiting their upregulation,.
Two pro-apoptotic genes whose expression is consistent with
this hypothesis are Nr4a3 and Nr4a1 (top two pro-apoptotic genes
in Group 1A, Figure 7 and Table S2), also known as Nor1 and
Nur77, respectively. Nr4a3/Nor1 is thought to be an important
regulator of cellular mechanisms including apoptosis. It was
originally identified from primary culture rat forebrain cells
undergoing apoptosis [33]. Overexpression of Nr4a3/Nor1 in
thymocytes results in their apoptosis [34]. Nr4a1/Nur77 is an
immediate early response gene expressed in a wide variety of
metabolically active tissues, including the heart; Nr4a1/Nur77
encodes an orphan nuclear receptor with pleiotropic physiological
roles including apoptosis induction (reviewed in [35]). Studies
examining the effects of trauma/HS in Nr4a3/Nor1- and Nr4a1/
Nur77-deficient mice are underway to determine if they are
protected from HS-mediated cardiac apoptosis.
Our findings raise the possibility that IL-6 administration may
be a useful adjuvant for resuscitation of trauma patients suffering
from severe HS to prevent development of HCC. Recombinant
human IL-6 has been given by subcutaneous and intravenous
injection to human subjects as part of Phase I/II clinical trials
performed to examine its potential thrombopoietic effects
following cancer chemotherapy. Our findings coupled with
previous reports that IL-6 was well tolerated in volunteers in
doses up to 30 mg/kg/day for 7 days [36] suggest that a single
intravenous bolus of IL-6 administered at the start of resuscitation
of hypotensive trauma patients deserves further study to assess
whether or not it prevents HCC and reduces mortality.
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